Peng Yu

发表

Optimal combination of biomarkers for predicting MCI to AD conversion selected using a bayesian framework

Yuan Qi, Robert A. Dean, Adam J. Schwarz, 2010, Alzheimer's & Dementia.

Robustness of automated hippocampal volumetry across magnetic resonance field strengths and repeat images

Daniel Rueckert, Clifford R. Jack, Robin Wolz, 2014, Alzheimer's & Dementia.

Chapter 10 – DTI in Development and Aging

P. Ellen Grant, David H. Salat, H. Diana Rosas, 2009 .

Relationship of Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's Disease

Peng Yu, P. Trzepacz, P. Yu, 2015, Dementia and Geriatric Cognitive Disorders.

Florbetapir positron emission tomography and cerebrospinal fluid biomarkers

Robert A. Dean, Peng Yu, R. Dean, 2015, Alzheimer's & Dementia.

Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size

Clifford R. Jack, Nick C. Fox, Robin Wolz, 2014, Neurobiology of Aging.

Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease

Andrew J. Saykin, Adam J. Schwarz, Peng Yu, 2013, Alzheimer's & Dementia.

Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.

Adam J Schwarz, Peng Yu, E. Siemers, 2012, Journal of Alzheimer's disease : JAD.

Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease

Martha Brumfield, Robin Wolz, Marina Boccardi, 2014, Alzheimer's & Dementia.